Drug Trial Radar · NCT07013201
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
135
Planned (sponsor's estimate)
Start
Sep 11, 2025
Primary completion
Jun 4, 2027
Study completion Jun 4, 2027
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Jun 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of adult participants with mild to severe palmoplantar pustulosis (PPP). Total study duration for each participants will be approximately 18 weeks, for an approximate total of 9 visits.
Conditions
- Palmoplantar Pustulosis
Interventions
Delgocitinib creamDrug
Topical application
Vehicle creamDrug
Topical application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Achieving at Least 75% Improvement in PPP Area and Severity Index (PPPASI) Score from Baseline (PPPASI-75) at Week 16Time frame: Baseline to Week 16
Locations
40 sites in 5 countries. Site status is shown where the registry gives one.
LEO Pharma Investigational Site
Fountain Valley, California · Recruiting
LEO Pharma Investigational Site
Douglasville, Georgia · Recruiting
LEO Pharma Investigational Site
West Bloomfield, Michigan · Recruiting
LEO Pharma Investigational Site
Elmhurst, New York · Recruiting
LEO Pharma Investigation Site
Mayfield Heights, Ohio · Recruiting
LEO Pharma Investigational Site
Portland, Oregon · Recruiting
LEO Pharma Investigational Site
Philadelphia, Pennsylvania · Recruiting
LEO Pharma Investigational Site
Calgary, Alberta, Canada · Recruiting
LEO Pharma Investigational Site
Edmonton, Alberta, Canada · Recruiting
LEO Pharma Investigational Site
Surrey, British Columbia, Canada · Recruiting
LEO Pharma Investigational Site
Winnipeg, Manitoba, Canada · Recruiting
LEO Pharma Investigational Site
Fredericton, New Brunswick, Canada · Recruiting
LEO Pharma Investigational Site
Hamilton, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Hamilton, Ontario, Canada · Completed
LEO Pharma Investigational Site
Markham, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Waterloo, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Montreal, Quebec, Canada · Recruiting
LEO Pharma Investigational Site
Bad Bentheim, Germany · Recruiting
LEO Pharma Investigational Site
Dresden, Germany · Recruiting
LEO Pharma Investigational Site
Göttingen, Germany · Recruiting
LEO Pharma Investigational Site
Hamburg, Germany · Recruiting
LEO Pharma Investigational Site
Kiel, Germany · Recruiting
LEO Pharma Investigational Site
Lübeck, Germany · Recruiting
LEO Pharma Investigational Site
Manheim, Germany · Recruiting
LEO Pharma Investigational Site
Münster, Germany · Recruiting
LEO Pharma Investigational Site
Osnabrück, Germany · Recruiting
LEO Pharma Investigational Site
Witten, Germany · Recruiting
LEO Pharma Investigational Site
Bialystok, Poland · Recruiting
LEO Pharma Investigational Site
Iwonicz-Zdrój, Poland · Completed
LEO Pharma Investigational Site
Lodz, Poland · Recruiting
LEO Pharma Investigational Site
Lublin, Poland · Recruiting
LEO Pharma Investigational Site
Rzeszów, Poland · Recruiting
LEO Pharma Investigational Site
Warsaw, Poland · Recruiting
LEO Pharma Investigational Site
Wroclaw, Poland · Recruiting
LEO Pharma Investigational Site
Wroclaw, Poland · Recruiting
LEO Pharma Investigational Site
Bristol, United Kingdom · Recruiting
LEO Pharma Investigational Site
London, United Kingdom · Recruiting
LEO Pharma Investigational Site
Newcastle upon Tyne, United Kingdom · Recruiting
LEO Pharma Investigational Site
Salford, United Kingdom · Recruiting
LEO Pharma Investigational Site
Stourbridge, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.